BD Names Shawn Bevec as Senior Vice President of Investor Relations

Core Insights - BD (Becton, Dickinson and Company) has appointed Shawn Bevec as senior vice president of investor relations, effective January 20, 2026 [1][2] Group 1: Leadership and Strategy - Bevec will lead the communication of BD's strategic progress to investors and the financial community, focusing on initiatives that enhance shareholder value [2][3] - Vitor Roque, the interim chief financial officer, will oversee Bevec until a new CFO is appointed [2] Group 2: Bevec's Background - Bevec has extensive experience in investor relations and equity research, previously serving as vice president of investor relations at Quest Diagnostics [3] - His background includes roles as a sell-side research analyst at Deutsche Bank and Susquehanna International Group, focusing on health care services and medical devices [3] - Bevec has also worked in research and development at Pfizer and Johnson & Johnson, providing a strong scientific and operational foundation [3] Group 3: BD Overview - BD is one of the largest pure-play medical technology companies, dedicated to advancing health through innovation in medical essentials, connected care, biopharmaceutical systems, and interventional solutions [5] - The company employs over 70,000 people globally and delivers billions of products annually, positively impacting global healthcare [5] - BD collaborates closely with customers to enhance outcomes, lower costs, increase clinical efficiency, improve safety, and expand access to healthcare [5]